Keywords: عامل انعقاد; Bee venom; Coagulation factor; Thrombin activity; Serine protease;
مقالات ISI عامل انعقاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل انعقاد; bleeding; coagulation factor; critical care; liver transplantation; point-of-care testing;
Keywords: عامل انعقاد; Coagulation factor; Membrane plasma separator; Plasma volume; Selective plasma exchange; Sieving coefficient; Supplementary fluid;
Keywords: عامل انعقاد; ApoV; Apoptotic vesicles; F; coagulation factor; FCS; fetal calf serum; FGA; fibrin generation assay; PS; phosphatidylserine; R5; RPMI-1640 with 5% FCS; SFM; serum-free medium; TF; tissue factor; TFPI; tissue factor pathway inhibitor; TGA; thrombin genera
Keywords: عامل انعقاد; APC; antigen-presenting cells; BcR; B cell receptor; EMA; European Medicines Agency; Fc; crystallizable fragment; FcγR; receptor for IgG Fc portion; FcRn; neonatal Fc receptor; FVIIa; activated factor VII; FVIII; factor VIII; GLP-1; glucagon-like peptide
Keywords: عامل انعقاد; Magnesium alloy; Blood compatibility; Bio-degradation; Coagulation factor
Keywords: عامل انعقاد; CHD; coronary artery disease; CAD; coronary artery disease; ACS; acute coronary syndrome; MI; myocardial infarction; UA; unstable angina; TF; tissue factor; Acute coronary syndrome; Myocardial infarction; Coagulation factor; Gene polymorphism; Anticoagula
Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients
Keywords: عامل انعقاد; Coagulation factor; Hemorrhage; Prothrombin complex concentrate; Surgery; Vitamin K antagonist;
Biochemical characterization of prothrombin complex concentrates in China
Keywords: عامل انعقاد; Prothrombin complex concentrates; Coagulation factor; Coagulation inhibitor; Thrombin inhibitory capacity; Specific activity; Thrombotic risk; PCCs; prothrombin complex concentrates; Fâ
¡; factor â
¡; Fâ
¦; factor â
¦; Fâ
¨; factor â
¨; Fâ
©; factor â
©;
Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies
Keywords: عامل انعقاد; AF; atrial fibrillation; aPCC; activated prothrombin complex concentrates; BID; twice daily; Cmax; maximal plasma concentration; F; coagulation factor; FEIBA; factor eight inhibitor bypass activity; PCC; prothrombin complex concentrates; rFVIIa; activated
Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: Potential role of protein Z as a powerful determinant of coagulation assays
Keywords: عامل انعقاد; F; coagulation factor; PT; prothrombin time; INR; international normalized ratio; TGA; thrombin generation assay; TF; tissue factor; ETP; endogenous thrombin potential;
C-type lectin-like proteins from snake venoms
Keywords: عامل انعقاد; C-type lectin-like proteins; Coagulation factor; Integrin; Rhodocetin;
Canine specific ELISA for coagulation factor VII
Keywords: عامل انعقاد; FVII deficiency; Haemostasis; Coagulation factor; ELISA; Plasma; Immunoassays;
Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma
Keywords: عامل انعقاد; coagulation factor; cytokines; haemostasis; plasma; transfusion;
Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel
Keywords: عامل انعقاد; Acute menorrhagia; Bleeding disorder; Hemostasis management; Consensus; Coagulation factor
The interaction of coagulation factor XII and monocyte/macrophages mediating peritoneal metastasis of epithelial ovarian cancer
Keywords: عامل انعقاد; Ovarian cancer; Monocyte; Coagulation factor; Metastasis
Human extrahepatic portal vein obstruction correlates with decreased factor VII and protein C transcription but increased hepatocyte proliferation
Keywords: عامل انعقاد; Extrahepatic portal vein obstruction; Coagulation factor; Proliferation; Apoptosis
Extrahepatic portal vein obstruction results in hepatocyte proliferation but a decrease in protein-C synthesis
Keywords: عامل انعقاد; Portal vein; Coagulation factor; Hepatocyte proliferation
The influence of molecular mass of sulfated propylene glycol ester of low-molecular-weight alginate on anticoagulant activities
Keywords: عامل انعقاد; Alginate; Sulfated propylene glycol alginate; Anticoagulant; Coagulation factor
A comparative study of hFIX expression mediated by rAAV8 and rAAV1 administrated intramuscularly
Keywords: عامل انعقاد; coagulation factor; gene therapy; rAAV1; rAAV8
Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma
Keywords: عامل انعقاد; Trauma; Hemostasis; Coagulation factor; Prothrombin time; International normalized ratioaPTT, activated partial thromboplastin time; INR, international normalized ratio; PT, prothrombin time
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination
Keywords: عامل انعقاد; aPTT; activated partial-thromboplastin time; AT; antithrombin; CT0; clotting time without melagatran; CTm; concentrations of melagatran; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetra-acetic acid; ETP; endogenous thrombin potential; F; coagula